AR and neoplasm: Tumor subtype analysis indicated that high AR activity is associated with a decreased risk for kidney renal clear cell carcinoma [KIRC; HR = 0.88; 95% confidence interval (CI), 0.82–0.97; P = 0.006; Fig. 1B] and stomach adenocarcinoma (STAD; HR = 0.91; 95% CI, 0.83–0.98; P = 0.020; Fig. 1B) and an increased risk for liver hepatocellular carcinoma (LIHC; HR = 1.09; 95% CI, 1.00–1.19; P = 0.048; Fig. 1B).